AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $407.23 million. The enterprise value is $383.74 million.
Important Dates
The last earnings date was Thursday, April 2, 2026, before market open.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 41.68 million shares outstanding. The number of shares has increased by 1.55% in one year.
| Current Share Class | 41.68M |
| Shares Outstanding | 41.68M |
| Shares Change (YoY) | +1.55% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 9.33% |
| Owned by Institutions (%) | 86.94% |
| Float | 34.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.31 |
| Forward PS | 1.25 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 3.80 |
| P/FCF Ratio | 272.89 |
| P/OCF Ratio | 92.21 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 255.31 |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.35 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 6.41 |
| Debt / FCF | 7.58 |
| Interest Coverage | -68.17 |
Financial Efficiency
Return on equity (ROE) is -17.47% and return on invested capital (ROIC) is -13.94%.
| Return on Equity (ROE) | -17.47% |
| Return on Assets (ROA) | -4.68% |
| Return on Invested Capital (ROIC) | -13.94% |
| Return on Capital Employed (ROCE) | -10.51% |
| Weighted Average Cost of Capital (WACC) | 6.52% |
| Revenue Per Employee | $464,778 |
| Profits Per Employee | -$46,499 |
| Employee Count | 675 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 2.36 |
Taxes
In the past 12 months, AngioDynamics has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.01% in the last 52 weeks. The beta is 0.44, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +8.01% |
| 50-Day Moving Average | 10.83 |
| 200-Day Moving Average | 10.90 |
| Relative Strength Index (RSI) | 38.53 |
| Average Volume (20 Days) | 489,226 |
Short Selling Information
The latest short interest is 1.78 million, so 4.28% of the outstanding shares have been sold short.
| Short Interest | 1.78M |
| Short Previous Month | 2.18M |
| Short % of Shares Out | 4.28% |
| Short % of Float | 5.11% |
| Short Ratio (days to cover) | 6.27 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $313.73 million and -$31.39 million in losses. Loss per share was -$0.76.
| Revenue | 313.73M |
| Gross Profit | 170.34M |
| Operating Income | -20.45M |
| Pretax Income | -31.38M |
| Net Income | -31.39M |
| EBITDA | -659,000 |
| EBIT | -20.45M |
| Loss Per Share | -$0.76 |
Full Income StatementBalance Sheet
The company has $37.81 million in cash and $11.39 million in debt, with a net cash position of $26.42 million or $0.63 per share.
| Cash & Cash Equivalents | 37.81M |
| Total Debt | 11.39M |
| Net Cash | 26.42M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 173.36M |
| Book Value Per Share | 4.16 |
| Working Capital | 89.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.45 million and capital expenditures -$2.95 million, giving a free cash flow of $1.50 million.
| Operating Cash Flow | 4.45M |
| Capital Expenditures | -2.95M |
| Depreciation & Amortization | 19.79M |
| Net Borrowing | -368,000 |
| Free Cash Flow | 1.50M |
| FCF Per Share | $0.04 |
Full Cash Flow StatementMargins
Gross margin is 54.30%, with operating and profit margins of -6.52% and -10.00%.
| Gross Margin | 54.30% |
| Operating Margin | -6.52% |
| Pretax Margin | -10.00% |
| Profit Margin | -10.00% |
| EBITDA Margin | -0.21% |
| EBIT Margin | -6.52% |
| FCF Margin | 0.48% |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.55% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.65% |
| FCF Yield | 0.37% |
Analyst Forecast
The average price target for AngioDynamics is $18.00, which is 84.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.00 |
| Price Target Difference | 84.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 5.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 1.88 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 5 |
